Catherine C. Turkel - Oct 12, 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Catherine C. Turkel/
Stock symbol
LEXX
Transactions as of
Oct 12, 2022
Transactions value $
$0
Form type
4
Date filed
10/13/2022, 05:16 PM
Previous filing
Sep 6, 2022
Next filing
Feb 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +1.6K +47.06% $0.00 5K Oct 12, 2022 Common Shares 1.6K $1.96 Direct
holding LEXX Stock Options 3.4K Oct 12, 2022 Common Shares 3.4K $3.04 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.